Progyny - Smart Cycles. Fertility Redefined. - $PGNY

Progyny transformed a broken fertility system into a multi-billion dollar business by aligning incentives for patients, employers, and providers. Dive into the story of this healthcare disruptor to understand its competitive moat, recent challenges, and whether its stock offers value for investors today.---Subscribe to our newsletter on LinkedIn https://www.linkedin.com/build-relation/newsletter-follow?entityUrn=7408775804387491842Follow us on X @emportop---Transcript https://empor.top/us/PGNY I. Introduction & Episode RoadmapII. The Fertility Crisis & Market ContextIII. Founding Story & The Insight (2015-2016)IV. Building the Flywheel: The Progyny ModelV. Scaling Through Enterprise Sales (2017-2019)VI. The IPO Journey (2019)VII. COVID, Demographic Shifts & Category Leadership (2020-2022)VIII. The Maturation Phase & Current Strategy (2023-Present)IX. The Business Model Deep DiveX. Porter's Five Forces AnalysisXI. Hamilton's Seven Powers AnalysisXII. Bull vs. Bear CaseXIII. Lessons for Builders & InvestorsXIV. Epilogue & Future OutlookXV. Key Performance Indicators to WatchXVI. Further Reading & Resources